https://www.selleckchem.com/pr....oducts/LY2228820.htm
Deferasirox is an oral chelator approved for iron overload, which has a potential side effect of renal Fanconi syndrome, with proximal tubular dysfunction and tubular acidosis. Monitoring of renal function is recommended, though no standard for monitoring exists. We aim to describe cases of deferasirox-associated Fanconi syndrome in adults and the renal monitoring required to detect these findings. We present a review of the literature and six cases from our institution of deferasirox-associated partial Fanconi syndrome in adult patie
Tycka om
Kommentar
Dela med sig
